Les Meilleurs doctors pour le traitement de neuroblastome en Israël - TOP-13 des médecins

Plus de 300 transplantations oncologiques pédiatriques réalisées – Ronit El Hasid travaille exclusivement avec des enfants au centre médical Sourasky (Ichilov).

• Chef du département d'onco-hématologie pédiatrique à l'hôpital pour enfants Dana Dwek
• Membre de l'Association américaine d'hématologie et de la Société israélienne d'hémato-oncologie pédiatrique
• Réaliser des transplantations de moelle osseuse et de sang de cordon ombilical pour des cas pédiatriques
• Formation suivie à l'hôpital City of Hope et dans des centres médicaux israéliens
• Plus de 50 articles publiés sur les méthodes oncologiques pédiatriques

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Le Dr Dvora Blumental a été formée en neuro-oncologie au Memorial Sloan-Kettering Cancer Center, de renommée mondiale. Elle dirige des services de neuro-oncologie majeurs depuis plus de 20 ans.

• Certifiée par le conseil de l'ordre et hautement expérimentée en neuro-oncologie
• Ancienne directrice de la neuro-oncologie au Huntsman Cancer Institute de l'Université de l'Utah
• Neuro-oncologue senior possédant une vaste expérience au Sourasky Medical Center
• Spécialisée dans les tumeurs du système nerveux central

Le Dr Levin se concentre sur les cancers pédiatriques et a été formé dans l'un des plus grands centres mondiaux d'oncologie des os et des tissus mous en Italie.

• Coordonner le traitement du cancer des os (sarcome) chez les enfants au centre médical Sourasky.
• Diriger le département d'hématologie et d'oncologie pédiatrique de Sourasky.
• Être membre de la Société israélienne d'hématologie et d'oncologie pédiatrique (ISPHO).
• Se spécialiser en hématologie et oncologie pédiatriques, traiter les troubles sanguins et les cancers.

Dirige l'Association Européenne des Sociétés de Neurochirurgie (EANS), un groupe professionnel de premier plan pour les chirurgiens. Le professeur Ram met à profit cette expertise de haut niveau pour traiter les tumeurs cérébrales pédiatriques, telles que le neuroblastome, à l'hôpital Ichilov de Tel Aviv.

• Spécialisation dans la chirurgie complexe des tumeurs cérébrales et de la moelle épinière
• Expertise dans les techniques avancées, notamment la cartographie cérébrale et la stimulation cérébrale profonde
• Formation en microchirurgie et en neurochirurgie guidée par l'image à travers l'Europe
• Recherche sur de nouvelles thérapies géniques contre le cancer du cerveau
• Lauréat du prix de la Fondation Goldhirsh pour le traitement innovant en neurologie

Inscrit sur la liste Forbes des meilleurs médecins d'Israël. Le Dr Goldstein dirige le département d'oncologie pédiatrique du centre médical Hadassah.

• Spécialisé depuis plus de vingt ans en oncologie et hémato-oncologie pédiatriques
• Expert en transplantation haplo-identique de moelle osseuse pour les enfants
• Se concentrer sur le rétinoblastome et la médecine de précision dans le traitement des cancers pédiatriques
• Membre de la Société Internationale d'Oncologie Pédiatrique (SIOP)

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Le professeur Miriam Ben-Harush est une spécialiste internationalement reconnue en oncologie pédiatrique et en transplantation de moelle osseuse à l'hôpital pour enfants Ruth Rappaport.

• Directrice de la division pédiatrique au centre médical Rambam
• Récipiendaire de la décoration de Chevalier de la Légion d'Honneur en France
• Nommée l'un des médecins les plus dévoués au monde par l'Association Médicale Mondiale
• Membre de groupes d'oncologie pédiatrique aux États-Unis et en Europe

Le Dr Hodaya Cohen est une obstétricienne-gynécologue certifiée au centre médical Hadassah.

• Avoir une grande expérience dans la gestion de tous les aspects de la santé des femmes
• Fournir des soins complets et compatissants à ses patientes
• Se spécialiser en obstétrique et gynécologie

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.